Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-019529
Filing Date
2024-07-12
Accepted
2024-07-12 17:29:54
Documents
1
Period of Report
2024-07-12

Document Format Files

Seq Description Document Type Size
1 form4-07122024_090750.html 4  
1 form4-07122024_090750.xml 4 6365
  Complete submission text file 0001415889-24-019529.txt   7825
Mailing Address C/O IMMUNOMEDICS, INC. 300 THE AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address
PFREUNDSCHUH PETER P. (Reporting) CIK: 0001585839 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38650 | Film No.: 241115329

Mailing Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169
Business Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169 212-847-9841
Y-mAbs Therapeutics, Inc. (Issuer) CIK: 0001722964 (see all company filings)

EIN.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)